Page 65 - GPD-1-2
P. 65

Gene & Protein in Disease                                                         circRNAs and cancer



            142. Wang Y, Lin Q, Song C, et al., 2020, Circ_0007841 promotes   153. Xia X, Li X, Li F, et al., 2019, A novel tumor suppressor protein
               the progression of multiple myeloma through targeting miR-  encoded by  circular  AKT3  RNA  inhibits glioblastoma
               338-3p/BRD4 signaling cascade. Cancer Cell Int, 20: 383.   tumorigenicity by competing with active phosphoinositide-
               https://doi.org/10.1186/s12935-020-01475-6         dependent Kinase-1. Mol Cancer, 18(1): 131.
            143. Li Z, Zhou Y, Yang G,  et al., 2019, Using circular RNA      https://doi.org/10.1186/s12943-019-1056-5
               SMARCA5 as a potential novel biomarker for hepatocellular   154. Kartal-Yandim M, Adan-Gokbulut A, Baran Y, 2016,
               carcinoma. Clin Chim Acta, 492: 37–44.             Molecular mechanisms of drug resistance and its reversal in
               https://doi.org/10.1016/j.cca.2019.02.001          cancer. Crit Rev Biotechnol, 36(4): 716–726.
            144. Zhang  H,  Deng  T,  Ge  S,  et al.,  2019,  Exosome  circRNA      https://doi.org/10.3109/07388551.2015.1015957
               secreted from adipocytes promotes the growth of   155. Zhou  R,  Wu Y, Wang  W,  et al.,  2018,  Circular  RNAs
               hepatocellular carcinoma by targeting deubiquitination-  (circRNAs) in cancer. Cancer Lett, 425: 134–142.
               related USP7. Oncogene, 38(15): 2844–2859.
                                                                  https://doi.org/10.1016/j.canlet.2018.03.035
               https://doi.org/10.1038/s41388-018-0619-z
                                                               156. Papatsirou M, Artemaki PI, Scorilas A, et al., 2020, The role
            145. Zhang PF, Gao C, Huang XY,  et al., 2020, Cancer cell-  of circular RNAs in therapy resistance of patients with solid
               derived exosomal circUHRF1 induces natural killer cell   tumors. Per Med, 17(6): 469–490.
               exhaustion and may cause resistance to anti-PD1 therapy in
               hepatocellular carcinoma. Mol Cancer, 19(1): 110.      https://doi.org/10.2217/pme-2020-0103
               https://doi.org/10.1186/s12943-020-01222-5      157. Kun-Peng Z, Xiao-Long M, Chun-Lin Z, 2018,
                                                                  Overexpressed circPVT1,  a potential new  circular  RNA
            146. Yang F, Liu DY, Guo JT,  et al., 2017, Circular RNA circ-  biomarker, contributes to doxorubicin and cisplatin
               LDLRAD3 as a biomarker in diagnosis of pancreatic cancer.   resistance of osteosarcoma cells by regulating ABCB1. Int J
               World J Gastroenterol, 23(47): 8345–8354.          Biol Sci, 14(3): 321–330.
               https://doi.org/10.3748/wjg.v23.i47.8345           https://doi.org/10.7150/ijbs.24360
            147. Zhao SY, Wang J, Ouyang SB, et al., 2018, Salivary circular   158. Sang Y, Chen B, Song X,  et al., 2019, Circrna_0025202
               RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as      regulates tamoxifen sensitivity and tumor progression via
               novel biomarkers for the diagnosis of oral squamous cell   regulating the miR-182-5p/FOXO3a axis in breast cancer.
               carcinoma. Cell Physiol Biochem, 47(6): 2511–2521.   Mol Ther, 27(9): 1638–1652.
               https://doi.org/10.1159/000491624                  https://doi.org/10.1016/j.ymthe.2019.05.011
            148. Zhu K, Niu L, Wang J,  et al., 2019, Circular RNA hsa_  159. Komseli ES, Pateras IS, Krejsgaard T,  et al., 2018, A
               circ_0000885  levels  are  increased  in  tissue  and  serum   prototypical non-malignant epithelial model to study
               samples from patients with osteosarcoma. Med Sci Monit,   genome dynamics and concurrently monitor micro-RNAs
               25: 1499–1505.                                     and proteins in situ during oncogene-induced senescence.
               https://doi.org/10.12659/MSM.914899                BMC Genomics, 19(1): 37.
            149. Zhu X, Wang X, Wei S,  et al., 2017, Hsa_circ_0013958:      https://doi.org/10.1186/s12864-017-4375-1
               A  circular RNA and potential novel biomarker for lung   160. Gokool A, Anwar F, Voineagu I, 2020, The landscape of
               adenocarcinoma. FEBS J, 284(14): 2170–2182.        circular RNA expression in the human brain. Biol Psychiatry,
               https://doi.org/10.1111/febs.14132                 87(3): 294–304.
            150. Ayers  D,  Vandesompele  J,  2017,  Influence  of  microRNAs      https://doi.org/10.1016/j.biopsych.2019.07.029
               and long non-coding RNAs in cancer chemoresistance.   161. Sachs N, Papaspyropoulos A, Ommen DD,  et al., 2019,
               Genes (Basel), 8(3): 95.                           Long-term expanding human airway organoids for disease
               https://doi.org/10.3390/genes8030095               modeling. EMBO J, 38(4): e100300.
            151. Ding C, Yi X, Wu X, et al., 2020, Exosome-mediated transfer      https://doi.org/10.15252/embj.2018100300
               of circRNA CircNFIX enhances temozolomide resistance in   162. Wiener DJ, Basak O, Asra P, et al., 2018, Establishment and
               glioma. Cancer Lett, 479: 1–12.                    characterization of a canine keratinocyte organoid culture
               https://doi.org/10.1016/j.canlet.2020.03.002       system. Vet Dermatol, 29(5): 375–e126.
            152. Shao F, Huang M, Meng F,  et al., 2018, Circular RNA      https://doi.org/10.1111/vde.12541
               signature predicts gemcitabine resistance of pancreatic   163. Cao J, Zhang X, Xu P, et al., 2021, Circular RNA circLMO7
               ductal adenocarcinoma. Front Pharmacol, 9: 584.
                                                                  acts as a microRNA-30a-3p sponge to promote gastric
               https://doi.org/10.3389/fphar.2018.00584           cancer progression via the WNT2/β-catenin pathway. J Exp


            Volume 1 Issue 2 (2022)                         18                     https://doi.org/10.36922/gpd.v1i2.138
   60   61   62   63   64   65   66   67   68   69   70